Your browser is no longer supported. Please, upgrade your browser.
Settings
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-3.27 Insider Own2.30% Shs Outstand356.66M Perf Week-9.41%
Market Cap4.33B Forward P/E3.44 EPS next Y3.52 Insider Trans0.37% Shs Float343.63M Perf Month-14.76%
Income-1143.00M PEG- EPS next Q0.90 Inst Own66.80% Short Float10.74% Perf Quarter-30.84%
Sales9.22B P/S0.47 EPS this Y-714.90% Inst Trans19.61% Short Ratio3.09 Perf Half Y41.05%
Book/sh11.23 P/B1.08 EPS next Y-4.40% ROA-2.60% Target Price- Perf Year-45.01%
Cash/sh3.40 P/C3.56 EPS next 5Y-9.73% ROE-30.20% 52W Range8.31 - 24.30 Perf YTD-16.46%
Dividend- P/FCF1.98 EPS past 5Y61.43% ROI-1.60% 52W High-50.08% Beta-0.38
Dividend %- Quick Ratio1.10 Sales past 5Y31.90% Gross Margin72.20% 52W Low45.95% ATR0.47
Employees21500 Current Ratio1.30 Sales Q/Q-7.70% Oper. Margin-4.20% RSI (14)26.61 Volatility4.18% 3.50%
OptionableYes Debt/Eq7.28 EPS Q/Q87.60% Profit Margin-12.40% Rel Volume0.77 Prev Close12.48
ShortableYes LT Debt/Eq7.03 EarningsNov 07 BMO Payout- Avg Volume11.95M Price12.13
Recom3.00 SMA20-12.75% SMA50-12.77% SMA200-10.92% Volume9,232,603 Change-2.80%
Aug-03-17Reiterated RBC Capital Mkts Sector Perform $19 → $21
Jun-16-17Initiated Cantor Fitzgerald Overweight $18
May-10-17Reiterated RBC Capital Mkts Sector Perform $18 → $19
Apr-20-17Reiterated JP Morgan Neutral $15 → $10
Mar-23-17Reiterated RBC Capital Mkts Sector Perform $21 → $18
Mar-06-17Reiterated Rodman & Renshaw Neutral $23 → $17
Feb-27-17Reiterated Mizuho Underperform $11 → $9
Feb-14-17Reiterated RBC Capital Mkts Sector Perform $29 → $22
Feb-10-17Reiterated Barclays Equal Weight $34 → $20
Jan-04-17Reiterated Piper Jaffray Underweight $16 → $11
Dec-15-16Downgrade Morgan Stanley Overweight → Equal-Weight $25 → $17
Nov-23-16Downgrade Mizuho Neutral → Underperform $25 → $11
Nov-14-16Reiterated Deutsche Bank Hold $29 → $24
Nov-10-16Reiterated Morgan Stanley Overweight $42 → $25
Nov-10-16Downgrade Rodman & Renshaw Buy → Neutral $81 → $23
Nov-09-16Reiterated RBC Capital Mkts Sector Perform $35 → $29
Oct-14-16Reiterated Deutsche Bank Hold $30 → $29
Oct-12-16Reiterated RBC Capital Mkts Sector Perform $36 → $35
Sep-20-16Resumed Deutsche Bank Hold $30
Aug-17-16Upgrade Morgan Stanley Equal-Weight → Overweight $33 → $42
Oct-20-17 08:43AM  Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options Zacks
Oct-19-17 11:47AM  3 Reasons to Stay Away From Valeant Pharmaceuticals Intl Inc Stock InvestorPlace
10:52AM  Buy More Shopify Inc (US) While Its Down InvestorPlace
09:00AM  Zacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi Zacks
Oct-18-17 04:59PM  Pricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
Oct-17-17 05:15AM  Shopify Inc (US) (SHOP) Stock: Has Citron Uncovered a Numbers Scheme? InvestorPlace
Oct-16-17 08:34PM  Valeant And One Of Its Subsidiaries Announce Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes PR Newswire
08:10AM  Today's Research Reports on Stocks to Watch: Celgene Corporation and Valeant Pharmaceuticals ACCESSWIRE
Oct-13-17 09:37PM  Future Outlook Of The Healthcare Industry And Valeant Pharmaceuticals International Inc (VRX) Simply Wall St.
03:08PM  Valeant: A ProblemOr Just More Noise? Barrons.com
03:01PM  Valeant Reports Positive Results on Psoriasis Drug Siliq Zacks
11:33AM  Its Time to Start Buying Beaten-Up Gilead Sciences, Inc. (GILD) Stock InvestorPlace
08:37AM  Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : October 13, 2017 Capital Cube
Oct-12-17 01:52PM  Shopify Inc (US) Stock News Is Dire, but So What? InvestorPlace
08:00AM  Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile PR Newswire
Oct-11-17 06:33PM  Ackman's Chipotle, Valeant Failures May Give ADP Holders Pause; NAFTA in Focus TheStreet.com
09:05AM  New Strong Sell Stocks for October 11th Zacks
Oct-10-17 07:36PM  [$$] Valeant's 2016 Stock Collapse Opened Door for Latigo Debt Play The Wall Street Journal
Oct-09-17 10:32AM  Valeant's Biggest Drug Gets a Shot at More Sales Barrons.com
Oct-06-17 01:47PM  Shopify Stock Will Plunge Almost 50% Says Prominent Short-Seller InvestorPlace
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
04:00AM  Why Investor Bullishness About AT&T Inc. (T) Stock Should Scare You InvestorPlace
Oct-05-17 07:46PM  VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors PR Newswire
04:03PM  Left Is Kind of Right on Shopify Inc (US) (SHOP) Stock InvestorPlace
12:43PM  Valeant Pharmaceuticals (VRX) Stock Begs Just One Key Question InvestorPlace
10:31AM  How to Approach Valeant Pharmaceuticals Intl Inc (VRX) Stock With Reason InvestorPlace
Oct-04-17 05:16PM  Solta Medical Receives FDA 510(k) Clearance for Thermage FLX System, Newest Generation Skin Smoothing Technology PR Newswire
11:29AM  Valeant Pharmaceuticals International, Inc. Value Analysis (NYSE:VRX) : October 4, 2017 Capital Cube
08:00AM  Solta Medical Receives FDA 510(k) Clearance for Thermage FLX System, Newest Generation Skin Smoothing Technology CNW Group
Oct-03-17 01:35PM  Fighting Debt Demons, Valeant Pharmaceuticals Just Priced a New Debt Offering Motley Fool
12:19PM  Valeant: Still Deep in Junk Territory Barrons.com
11:15AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Set for Near-100% Return InvestorPlace
08:17AM  Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : October 3, 2017 Capital Cube
08:00AM  Today's Research Reports on Trending Tickers: Dynavax Technologies and Valeant Pharmaceuticals ACCESSWIRE
08:00AM  Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe PR Newswire
08:00AM  Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe CNW Group
07:00AM  Valeant Will Release Third-Quarter 2017 Financial Results On November 7 CNW Group
Oct-02-17 07:47PM  Valeant Announces Pricing Of Private Offering Of Senior Secured Notes PR Newswire
07:47PM  Valeant Announces Pricing Of Private Offering Of Senior Secured Notes CNW Group
02:03PM  Valeant Digs Into Its Leverage Spiral Bloomberg
12:12PM  Today's charts: Gun stocks rally; GM shares climb; HPE let Russia review cyber defense software Yahoo Finance
09:49AM  Valeant Pharmaceuticals International, Inc -- Moody's assigns Ba3 to Valeant's secured notes; negative outlook Moody's
07:51AM  Why Valeant Stock (VRX) Cant Survive the Coming Correction InvestorPlace
07:47AM  Valeant to borrow $1 billion in bond market to help fund repayment of existing debt MarketWatch
07:36AM  Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount CNW Group
07:35AM  Valeant Announces Launch Of Private Offering Of Senior Secured Notes CNW Group
07:10AM  Corporate News Blog - Valeant Agrees to Sell iNova Pharma; Set to Use Sale Proceeds to Repay Term Loan Debt ACCESSWIRE
Sep-30-17 12:32AM  [$$] More Borrowing Is Not the Answer at Valeant The Wall Street Journal
Sep-29-17 05:08PM  [$$] More Borrowing Is Not the Answer at Valeant The Wall Street Journal
01:21PM  Valeant higher as $930 million sale of iNova closes CNBC Videos
10:48AM  Debt Worries Outweigh Specialty Pharma Pipeline Potential Barrons.com
10:35AM  Valeant: Opportunity Time? Barrons.com
08:00AM  Today's Research Reports on Trending Tickers: PTC Therapeutics and Valeant Pharmaceuticals ACCESSWIRE
07:00AM  Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group PR Newswire
07:00AM  Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group CNW Group
Sep-28-17 03:37PM  Could Being Undervalued Boost Rite Aid (RAD) Stock? InvestorPlace
11:27AM  UPDATE: Why Valeant is Sinking Barrons.com
Sep-27-17 09:22PM  Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans CNW Group
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
07:00AM  Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference PR Newswire
Sep-26-17 11:25AM  Is Teva Pharmaceutical (TEVA) Stock Worth the Risk? InvestorPlace
07:37AM  How Low Does Valeant Pharmaceuticals' Debt Really Need to Go? Motley Fool
Sep-25-17 11:00AM  Why Valeant Pharmaceuticals (VRX) Stock is Still no Bargain InvestorPlace
09:56AM  Valeant Could Gain 33%. It's Still Not a Buy. Barrons.com
Sep-22-17 01:25PM  Generic Drug Makers Face Pricing Issues That Other Pharmas Don't Investor's Business Daily
Sep-21-17 09:55AM  Should Value Investors Consider Valeant Pharmaceuticals International (VRX) Stock? Zacks
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
Sep-19-17 11:01AM  GlassHouse: NuVasive Using The 'Valeant Playbook' To Deceive Investors Benzinga
Sep-18-17 10:33AM  Valeant Pharmaceuticals: Is A New Drug Approval On The Horizon? Barrons.com
09:54AM  What You Should Know About The Drug Approval Valeant Could Receive This Week Benzinga
07:00AM  Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference CNW Group
Sep-15-17 09:00AM  Valeant Commits $200,000 to Support Hurricane Relief Efforts CNW Group
08:26AM  Own Alphabet Inc. Stock? Antitrust Is on the Horizon InvestorPlace
Sep-12-17 09:14AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Is STILL Too Ugly to Buy InvestorPlace
08:01AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
08:00AM  Today's Research Reports on Trending Tickers: Endo International and Valeant Pharmaceuticals ACCESSWIRE
Sep-11-17 02:35PM  DST faces class action over profit-sharing plan American City Business Journals
09:49AM  Buy Amazon, short Valeant among the top picks out of last year's Delivering Alpha CNBC
Sep-08-17 02:00PM  Follow the Crucial '$20 Level Rule' When Trading Stocks TheStreet.com
10:06AM  This Clear Catalyst Sent Valeant Pharmaceuticals Intl. Inc. 18% Lower in August Motley Fool
08:00AM  $20 Should Be Your Cutoff Point TheStreet.com
Sep-06-17 07:00AM  Valeant To Participate At The Morgan Stanley Global Healthcare Conference PR Newswire
Sep-05-17 04:51PM  Why Mallinckrodt Got Crushed Barrons.com
09:20AM  Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118 PR Newswire
09:20AM  Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118 CNW Group
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
07:20AM  Corporate News Blog - Intellipharmaceutics International Announces Appointment of CFO ACCESSWIRE
Sep-02-17 12:03PM  Better Buy: Valeant Pharmaceuticals International, Inc. vs. Rite Aid Corporation Motley Fool
Sep-01-17 05:39PM  Valeant (VRX) Continues to Lose Ground: Can It Bounce Back? Zacks
09:19AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Be Just Fine InvestorPlace
09:02AM  The Simple Reason I Won't Buy Intrexon Motley Fool
Aug-31-17 09:30AM  Wilmington company sues former partner following work for Salix, Valeant American City Business Journals
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
Aug-30-17 02:27PM  A Group Of Investors Is On A Mission To Help Traders Give Back Through Charity Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Rexahn Pharmaceuticals and Valeant Pharmaceuticals ACCESSWIRE
Aug-29-17 04:41PM  Why Finish Line Inc (FINL), Valeant Pharmaceuticals Intl Inc (VRX) and Best Buy Co Inc (BBY) Are 3 of Todays Worst Stocks InvestorPlace -6.96%
01:14PM  Valeant: No Fundamental Reasons for Today's Selloff? Barrons.com
12:43PM  Why Did Valeant Pharmaceuticals (VRX) Stock Fall Today? Zacks
10:23AM  Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic InvestorPlace
09:34AM  Valeant Pharmaceuticals: Weakness, Weakness Everywhere? Barrons.com
Valeant Pharmaceuticals International, Inc. operates as a pharmaceutical and medical device company worldwide. It operates in three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The company offers Lotemax gel for the treatment of inflammation and pain following ocular surgery; Ocuvite, a lutein eye vitamin and mineral supplement; PreserVision, an antioxidant eye vitamin and mineral supplement; ReNu Multiplus products; Biotrue multi-purpose solution for healthy contact lens wear; Artelac to treat dry eyes; Boston, a cleansing solution for gas permeable contact lenses; and Bedoyecta, a vitamin B complex. It also provides SofLens daily disposable contact lenses; ophthalmic surgical products; PureVision, a silicone hydrogel; Biotrue ONEday daily disposable contact lenses; Bausch + Lomb Ultra, a silicone hydrogel replacement contact lens; and medical device systems. In addition, the company offers Xifaxan for the treatment of irritable bowel syndrome; Provenge for the treatment of prostate cancer; Uceris to get ulcerative colitis under control; Arestin, a subgingival sustained-release antibiotic; Jublia for the treatment of onychomycosis; Solodyn for the treatment of acne; Elidel to treat skin conditions; and Glumetza tablets to enhance glycemic control. Further, it provides Wellbutrin XL for the treatment of major depressive disorder; Isuprel injections; Xenazine for the treatment of chorea; Nitropress for the reduction of blood pressure of patients in hypertensive crises; Cuprimine to treat Wilson's disease; Zegerid to treat certain stomach and esophagus problems; Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; and Latanoprost medicines to treat a type of glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DE SCHUTTER RICHARD UDirectorAug 21Buy14.3310,000143,29682,379Aug 22 04:39 PM
DE SCHUTTER RICHARD UDirectorMay 11Buy13.9020,000278,00070,572May 15 05:19 PM
DE SCHUTTER RICHARD UDirectorMar 15Buy10.8010,000108,00025,190Mar 16 05:12 PM
Herendeen PaulEVP and CFOMar 14Buy10.7224,000257,280174,000Mar 16 05:04 PM
ValueAct Holdings, L.P.DirectorMar 14Buy10.823,000,00032,465,00016,937,431Mar 16 04:31 PM
Pershing Square Capital ManageDirectorMar 13Sale11.0018,114,432199,258,7520Mar 14 04:14 PM
Ross Thomas W. Sr.DirectorDec 14Buy14.735,00073,65026,822Dec 16 04:19 PM
Pershing Square Capital ManageDirectorDec 12Sale14.853,476,69051,628,84718,114,432Dec 13 04:14 PM